SecSonar.com

Universe Pharmaceuticals Inc. (UPC)

Universe Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Universe Pharmaceuticals Inc. (UPC) is a Drug Manufacturers - Specialty & Generic company based in CN with a market capitalization of $1.8M. Revenue declined 22.4% year-over-year and free cash flow was negative at -$5.4M. This page tracks UPC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CN · 225 employees · IPO Mar 23, 2021

Valuation

Valuation & price

$2.76 · as of May 17, 2026 · -77.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.03

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$9.46$5.86$2.25Jul 25Dec 25Jul 26Jul 7, 25$3.61Jul 9, 25$3.64Jul 11, 25$3.80Jul 15, 25$3.72Jul 17, 25$3.55Jul 21, 25$3.48Jul 23, 25$3.83Jul 25, 25$3.84Jul 29, 25$4.02Jul 31, 25$3.54Aug 4, 25$3.67Aug 6, 25$3.52Aug 11, 25$3.58Aug 13, 25$4.40Aug 15, 25$3.52Aug 19, 25$3.42Aug 21, 25$3.43Aug 25, 25$3.56Aug 27, 25$3.68Aug 29, 25$3.55Sep 3, 25$3.75Sep 5, 25$3.55Sep 9, 25$4.00Sep 11, 25$4.08Sep 16, 25$4.13Sep 18, 25$4.15Sep 22, 25$4.44Sep 24, 25$4.16Sep 26, 25$4.44Sep 30, 25$4.20Oct 2, 25$4.49Oct 6, 25$4.74Oct 8, 25$9.46Oct 10, 25$6.71Oct 14, 25$6.35Oct 16, 25$5.45Oct 21, 25$5.25Oct 23, 25$5.18Oct 27, 25$4.92Oct 29, 25$4.82Oct 31, 25$4.72Nov 4, 25$4.27Nov 6, 25$3.96Nov 10, 25$3.70Nov 12, 25$3.68Nov 14, 25$3.65Nov 18, 25$3.57Nov 20, 25$3.50Nov 25, 25$3.44Nov 28, 25$3.94Dec 2, 25$3.58Dec 4, 25$4.12Dec 8, 25$4.45Dec 10, 25$4.23Dec 12, 25$3.98Dec 16, 25$3.68Dec 18, 25$3.64Dec 22, 25$3.78Dec 24, 25$4.29Dec 29, 25$4.42Jan 2, 26$4.16Jan 6, 26$4.00Jan 8, 26$4.22Jan 12, 26$4.16Jan 14, 26$4.19Jan 16, 26$4.51Jan 21, 26$4.06Jan 23, 26$4.07Jan 27, 26$4.10Jan 29, 26$4.16Feb 2, 26$4.41Feb 4, 26$4.39Feb 9, 26$3.97Feb 11, 26$3.62Feb 13, 26$2.86Feb 18, 26$2.76Feb 20, 26$2.92Feb 24, 26$2.99Feb 26, 26$2.82Mar 2, 26$2.72Mar 4, 26$2.64Mar 6, 26$2.72Mar 10, 26$2.38Mar 12, 26$2.43Mar 17, 26$2.65Mar 19, 26$2.46Mar 23, 26$2.32Mar 25, 26$2.25Mar 27, 26$2.73Mar 31, 26$2.75Apr 2, 26$3.16Apr 7, 26$2.88Apr 9, 26$2.95Apr 13, 26$3.13Apr 15, 26$3.27Apr 17, 26$3.38Apr 22, 26$3.30Apr 24, 26$3.28Apr 28, 26$3.09Apr 30, 26$3.23May 4, 26$3.20May 6, 26$2.82May 8, 26$2.80May 12, 26$2.60May 14, 26$2.68May 18, 26$2.58May 20, 26$2.70May 22, 26$2.88May 28, 26$2.85Jun 1, 26$3.37Jun 3, 26$3.44Jun 5, 26$3.27Jun 9, 26$3.37Jun 11, 26$3.25Jun 15, 26$3.12Jun 17, 26$2.91Jun 22, 26$2.85Jun 24, 26$2.95Jun 26, 26$2.96Jul 2, 26$6.32
$2.2552-week range$12.18
Loading valuation history…

Fundamentals

Key fundamentals

$1.8M

Market cap

-22.4%

Revenue growth (YoY)

35.3%

Gross margin

-$5.4M

Free cash flow (USD)

-$24.3M

Net debt

Net cash position

-42.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$28.5MFY 2019$33.2MFY 2020$30.7MFY 2021$48.0MFY 2022$40.1MFY 2023$32.3MFY 2024$23.0MFY 2025$17.9M
$28.5M$17.9M

Free cash flow by year

2018 → 2025

FY 2018$4.3MFY 2019$13.1MFY 2020$6.1MFY 2021$-15.6MFY 2022$-1.4MFY 2023$1.1MFY 2024$-9.9MFY 2025$-5.4M
$4.3M-$5.4M

Gross margin by year

2021 → 2025

FY 202152.8%FY 202254.5%FY 202331.9%FY 202426.4%FY 202535.3%
52.8%35.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: —

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingShare Purchase AgreementJun 26, 2026Filing
  • 6-K filingGrant of SharesMay 14, 2026Filing
  • 6-K filingEquity Incentive PlanApr 16, 2026Filing

Questions

Frequently asked questions

What is Universe Pharmaceuticals Inc.'s market cap?

Universe Pharmaceuticals Inc. (UPC) has a market capitalization of $1.8M.

What is UPC's P/E ratio?

A meaningful P/E ratio is not available for UPC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is UPC's price-to-book (P/B) ratio?

UPC trades at 0.03 times book value per share.

Are insiders buying UPC stock?

SEC Form 4 filings show no open-market insider buys at Universe Pharmaceuticals Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

SNOA

Sonoma Pharmaceuticals, Inc.

$2M

SBFM

Sunshine Biopharma, Inc.

$1.4M

SXTC

China SXT Pharmaceuticals, Inc.

$1.3M

CPHI

China Pharma Holdings, Inc.

$2.4M

IMCC

IM Cannabis Corp.

$1M

AKAN

Akanda Corp.

$706.9K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.